BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1555584)

  • 1. High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin).
    Maurer P; Mayer U; Bruch M; Jenö P; Mann K; Landwehr R; Engel J; Timpl R
    Eur J Biochem; 1992 Apr; 205(1):233-40. PubMed ID: 1555584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV.
    Maurer P; Hohenadl C; Hohenester E; Göhring W; Timpl R; Engel J
    J Mol Biol; 1995 Oct; 253(2):347-57. PubMed ID: 7563094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV.
    Mayer U; Aumailley M; Mann K; Timpl R; Engel J
    Eur J Biochem; 1991 May; 198(1):141-50. PubMed ID: 2040276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin).
    Pottgiesser J; Maurer P; Mayer U; Nischt R; Mann K; Timpl R; Krieg T; Engel J
    J Mol Biol; 1994 May; 238(4):563-74. PubMed ID: 8176746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues.
    Engel J; Taylor W; Paulsson M; Sage H; Hogan B
    Biochemistry; 1987 Nov; 26(22):6958-65. PubMed ID: 3427055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium affinity, cooperativity, and domain interactions of extracellular EF-hands present in BM-40.
    Busch E; Hohenester E; Timpl R; Paulsson M; Maurer P
    J Biol Chem; 2000 Aug; 275(33):25508-15. PubMed ID: 10801822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens.
    Sasaki T; Göhring W; Mann K; Maurer P; Hohenester E; Knäuper V; Murphy G; Timpl R
    J Biol Chem; 1997 Apr; 272(14):9237-43. PubMed ID: 9083057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of the extracellular calcium-binding protein BM-40/secreted protein, acidic, rich in cysteine/osteonectin from the nematode Caenorhabditis elegans.
    Maurer P; Sasaki T; Mann K; Göhring W; Schwarzbauer JE; Timpl R
    Eur J Biochem; 1997 Aug; 248(1):209-16. PubMed ID: 9310380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
    Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
    J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes of bovine bone osteonectin induced by interaction with calcium.
    Takita H; Kuboki Y
    Calcif Tissue Int; 1995 Jun; 56(6):559-65. PubMed ID: 7648487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens.
    Sasaki T; Miosge N; Timpl R
    Matrix Biol; 1999 Oct; 18(5):499-508. PubMed ID: 10601737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid).
    Bolander ME; Young MF; Fisher LW; Yamada Y; Termine JD
    Proc Natl Acad Sci U S A; 1988 May; 85(9):2919-23. PubMed ID: 2834720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.
    Giudici C; Raynal N; Wiedemann H; Cabral WA; Marini JC; Timpl R; Bächinger HP; Farndale RW; Sasaki T; Tenni R
    J Biol Chem; 2008 Jul; 283(28):19551-60. PubMed ID: 18487610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal Ca2+-binding domain of SPARC confers anti-spreading activity to human urothelial cells.
    Delostrinos CF; Hudson AE; Feng WC; Kosman J; Bassuk JA
    J Cell Physiol; 2006 Jan; 206(1):211-20. PubMed ID: 16121393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of calcium binding to brain spectrin.
    Wallis CJ; Wenegieme EF; Babitch JA
    J Biol Chem; 1992 Mar; 267(7):4333-7. PubMed ID: 1537825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
    Lane TF; Sage EH
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility.
    Schwarzbauer JE; Spencer CS
    Mol Biol Cell; 1993 Sep; 4(9):941-52. PubMed ID: 8257796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40.
    Hohenester E; Maurer P; Timpl R
    EMBO J; 1997 Jul; 16(13):3778-86. PubMed ID: 9233787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal region of alpha-dystroglycan is an autonomous globular domain.
    Brancaccio A; Schulthess T; Gesemann M; Engel J
    Eur J Biochem; 1997 May; 246(1):166-72. PubMed ID: 9210479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a novel extracellular Ca(2+)-binding module in BM-40.
    Hohenester E; Maurer P; Hohenadl C; Timpl R; Jansonius JN; Engel J
    Nat Struct Biol; 1996 Jan; 3(1):67-73. PubMed ID: 8548457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.